
Bridget E. Bunner
Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1644, 1647 |
| Total Applications | 1463 |
| Issued Applications | 725 |
| Pending Applications | 157 |
| Abandoned Applications | 602 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8523388
[patent_doc_number] => 20120322795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 13/325564
[patent_app_country] => US
[patent_app_date] => 2011-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23050
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13325564
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/325564 | Biarylamide inhibitors of leukotriene production | Dec 13, 2011 | Issued |
Array
(
[id] => 8043575
[patent_doc_number] => 20120071527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'THERAPEUTIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/308197
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19199
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071527.pdf
[firstpage_image] =>[orig_patent_app_number] => 13308197
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/308197 | Therapeutic compounds | Nov 29, 2011 | Issued |
Array
(
[id] => 7818596
[patent_doc_number] => 20120065216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'QUINAZOLINEDIONE DERIVATIVES AS PARP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/298934
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9288
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065216.pdf
[firstpage_image] =>[orig_patent_app_number] => 13298934
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/298934 | Quinazolinedione derivatives as PARP inhibitors | Nov 16, 2011 | Issued |
Array
(
[id] => 9339688
[patent_doc_number] => 20140066470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'NOVEL FORMULATIONS OF WATER-INSOLUBLE CHEMICAL COMPOUNDS AND METHODS OF USING A FORMULATION OF COMPOUND FL118 FOR CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/881785
[patent_app_country] => US
[patent_app_date] => 2011-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 22043
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881785 | Formulations of water-insoluble chemical compounds and methods of using a formulation of compound FL118 for cancer therapy | Oct 30, 2011 | Issued |
Array
(
[id] => 9552462
[patent_doc_number] => 08759514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Method for separation of HMX and RDX'
[patent_app_type] => utility
[patent_app_number] => 13/281648
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4084
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13281648
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/281648 | Method for separation of HMX and RDX | Oct 25, 2011 | Issued |
Array
(
[id] => 9245400
[patent_doc_number] => 08609681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Spirocyclic nitriles as protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/248366
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32095
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13248366
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/248366 | Spirocyclic nitriles as protease inhibitors | Sep 28, 2011 | Issued |
Array
(
[id] => 7744412
[patent_doc_number] => 20120022050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/249166
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82067
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022050.pdf
[firstpage_image] =>[orig_patent_app_number] => 13249166
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/249166 | Histamine H3 inverse agonists and antagonists and methods of use thereof | Sep 28, 2011 | Issued |
Array
(
[id] => 8141273
[patent_doc_number] => 20120095185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'PROCESS FOR CHELATING COPPER IONS USING CB-TE2A BIFUNCTIONAL CHELATE'
[patent_app_type] => utility
[patent_app_number] => 13/237507
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11253
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095185.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237507
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237507 | PROCESS FOR CHELATING COPPER IONS USING CB-TE2A BIFUNCTIONAL CHELATE | Sep 19, 2011 | Abandoned |
Array
(
[id] => 7663673
[patent_doc_number] => 20110312942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/217659
[patent_app_country] => US
[patent_app_date] => 2011-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10691
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312942.pdf
[firstpage_image] =>[orig_patent_app_number] => 13217659
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/217659 | AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION | Aug 24, 2011 | Abandoned |
Array
(
[id] => 7663674
[patent_doc_number] => 20110312943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/217729
[patent_app_country] => US
[patent_app_date] => 2011-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10717
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312943.pdf
[firstpage_image] =>[orig_patent_app_number] => 13217729
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/217729 | Aurora kinase inhibitors for inhibiting mitotic progression | Aug 24, 2011 | Issued |
Array
(
[id] => 8408674
[patent_doc_number] => RE043688
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2012-09-25
[patent_title] => 'Compositions and methods related to serotonin 5-HT1A receptors'
[patent_app_type] => reissue
[patent_app_number] => 13/187728
[patent_app_country] => US
[patent_app_date] => 2011-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 9279
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187728
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/187728 | Compositions and methods related to serotonin 5-HT1A receptors | Jul 20, 2011 | Issued |
Array
(
[id] => 10888326
[patent_doc_number] => 08912322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Aza-dibenzocyclooctynes and methods of making and using same'
[patent_app_type] => utility
[patent_app_number] => 13/187643
[patent_app_country] => US
[patent_app_date] => 2011-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 9849
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187643
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/187643 | Aza-dibenzocyclooctynes and methods of making and using same | Jul 20, 2011 | Issued |
Array
(
[id] => 7561963
[patent_doc_number] => 20110275796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'Process for the Production of 3-Oxo-pregn-4-ene-21,17-carbolactones by the Metal-Free Oxidation of 17-(3-Hydroxypropyl)-3,17-dihydroxyandrostanes'
[patent_app_type] => utility
[patent_app_number] => 13/187672
[patent_app_country] => US
[patent_app_date] => 2011-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4474
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275796.pdf
[firstpage_image] =>[orig_patent_app_number] => 13187672
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/187672 | Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes | Jul 20, 2011 | Issued |
Array
(
[id] => 10888326
[patent_doc_number] => 08912322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Aza-dibenzocyclooctynes and methods of making and using same'
[patent_app_type] => utility
[patent_app_number] => 13/187643
[patent_app_country] => US
[patent_app_date] => 2011-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 9849
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187643
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/187643 | Aza-dibenzocyclooctynes and methods of making and using same | Jul 20, 2011 | Issued |
Array
(
[id] => 8571831
[patent_doc_number] => 08338478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Derivatives of 3,3-diphenylpropylamines'
[patent_app_type] => utility
[patent_app_number] => 13/161049
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20630
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13161049
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/161049 | Derivatives of 3,3-diphenylpropylamines | Jun 14, 2011 | Issued |
Array
(
[id] => 8733941
[patent_doc_number] => 20130079510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'CYCLIC CARBODIIMIDE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/702429
[patent_app_country] => US
[patent_app_date] => 2011-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17757
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702429
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/702429 | CYCLIC CARBODIIMIDE COMPOUND | Jun 5, 2011 | Abandoned |
Array
(
[id] => 8815384
[patent_doc_number] => 20130116429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Gadobutrol Preparation in a One-Pot Process by means of DMF Acetal and N-Methylimidazole'
[patent_app_type] => utility
[patent_app_number] => 13/701914
[patent_app_country] => US
[patent_app_date] => 2011-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1731
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701914
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701914 | Gadobutrol Preparation in a One-Pot Process by means of DMF Acetal and N-Methylimidazole | May 30, 2011 | Abandoned |
Array
(
[id] => 12326208
[patent_doc_number] => 09944722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Chelator and use thereof
[patent_app_type] => utility
[patent_app_number] => 13/701074
[patent_app_country] => US
[patent_app_date] => 2011-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9467
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701074
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701074 | Chelator and use thereof | May 29, 2011 | Issued |
Array
(
[id] => 9127233
[patent_doc_number] => 08575182
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-05
[patent_title] => '6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions'
[patent_app_type] => utility
[patent_app_number] => 13/116725
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17569
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116725
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/116725 | 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions | May 25, 2011 | Issued |
Array
(
[id] => 11198322
[patent_doc_number] => 09428524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Synthetic process for the manufacture of ecteinascidin compounds'
[patent_app_type] => utility
[patent_app_number] => 13/699052
[patent_app_country] => US
[patent_app_date] => 2011-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17041
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699052
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699052 | Synthetic process for the manufacture of ecteinascidin compounds | May 23, 2011 | Issued |